U.S. flag

An official website of the United States government

NM_000535.7(PMS2):c.137G>A (p.Ser46Asn) AND Endometrial carcinoma

Germline classification:
Likely pathogenic (1 submission)
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000076806.5

Allele description [Variation Report for NM_000535.7(PMS2):c.137G>A (p.Ser46Asn)]

NM_000535.7(PMS2):c.137G>A (p.Ser46Asn)

Gene:
PMS2:PMS1 homolog 2, mismatch repair system component [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p22.1
Genomic location:
Preferred name:
NM_000535.7(PMS2):c.137G>A (p.Ser46Asn)
HGVS:
  • NC_000007.14:g.6005918C>T
  • NG_008466.1:g.8189G>A
  • NG_050738.1:g.1668C>T
  • NM_000535.7:c.137G>AMANE SELECT
  • NM_001322003.2:c.-269G>A
  • NM_001322004.2:c.-242-1860G>A
  • NM_001322005.2:c.-269G>A
  • NM_001322006.2:c.137G>A
  • NM_001322007.2:c.-79G>A
  • NM_001322008.2:c.-52-1860G>A
  • NM_001322009.2:c.-269G>A
  • NM_001322010.2:c.-242-1860G>A
  • NM_001322011.2:c.-748G>A
  • NM_001322012.2:c.-748G>A
  • NM_001322013.2:c.-269G>A
  • NM_001322014.2:c.137G>A
  • NM_001322015.2:c.-348G>A
  • NP_000526.2:p.Ser46Asn
  • NP_001308935.1:p.Ser46Asn
  • NP_001308943.1:p.Ser46Asn
  • LRG_161t1:c.137G>A
  • LRG_161:g.8189G>A
  • NC_000007.13:g.6045549C>T
  • NM_000535.5:c.137G>A
  • NM_000535.6:c.137G>A
  • NR_136154.1:n.224G>A
Protein change:
S46N
Links:
dbSNP: rs121434629
NCBI 1000 Genomes Browser:
rs121434629
Molecular consequence:
  • NM_001322003.2:c.-269G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322005.2:c.-269G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322007.2:c.-79G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322009.2:c.-269G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322011.2:c.-748G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322012.2:c.-748G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322013.2:c.-269G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322015.2:c.-348G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322004.2:c.-242-1860G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322008.2:c.-52-1860G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322010.2:c.-242-1860G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000535.7:c.137G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322006.2:c.137G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322014.2:c.137G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_136154.1:n.224G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Endometrial carcinoma
Synonyms:
Endometrial carcinoma, somatic
Identifiers:
MONDO: MONDO:0002447; MedGen: C0476089; OMIM: 608089; Human Phenotype Ontology: HP:0012114

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000592922Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR)

See additional submitters

no assertion criteria provided
Likely pathogenicunknownclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR), SCV000592922.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The PMS2 p.Ser46Asn variant was identified in 2 of 370 proband chromosomes (frequency: 0.005) from individuals or families with colorectal cancer (Senter 2008, Everett 2014). The variant was also identified in dbSNP (ID: rs121434629) as "With Pathogenic allele", ClinVar (classified as uncertain significance by InSight; as likely pathogenic by Invitae; and as pathogenic by Mayo Clinic), GeneInsight-COGR, Mismatch Repair Genes Variant Database, and Insight Hereditary Tumors database (4x). The variant was not identified in Cosmic, MutDB, or Zhejiang University databases. The variant was identified in control databases in 2 of 240416 chromosomes at a frequency of 0.000008 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the European population in 2 of 107732 chromosomes (freq: 0.00002), while the variant was not observed in the African, Other, Latino, Ashkenazi Jewish, East Asian, Finnish, or South Asian populations. The p.Ser46 residue is conserved across mammals and other organisms and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) suggest that the variant may impact the protein; however, this information is not predictive enough to assume pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. The variant was reported as a biallelic gene mutation, identified with the PMS2 c.137G>T mutation in an individual with sigmoid adenocarcinoma; the tumour had high microsatellite instability and both the tumour and normal tissue were PMS2-deficient on IHC (Jackson 2008). In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more pathogenic role for this variant. This variant is classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024